Načítá se...
O7. Advantages and disadvantages of Cisplatin or carboplatin in adjuvant chemotherapy of NSCLC
BACKGROUND: Adjuvant chemotherapy (AC) of non-small cell lung carcinoma (NSCLC) is used in stages IB, II and III. Platinum based doublets are applied, combination with vinorelbine is a preferable regimen. AC with cisplatin (CDDP) is considered more effective than carboplatin (CBDCA), nevertheless th...
Uloženo v:
| Vydáno v: | Transl Lung Cancer Res |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Pioneer Bioscience Publishing Company
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4367780/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.AB007 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|